AI for Drug Development & Pharma Strategy

Available for Group Training

Apply AI across discovery, clinical development and due diligence to accelerate decision-making and unlock pipeline value

This course is currently not scheduled however it can be delivered for your team. To register your interest, complete the form below

We Can Deliver This Course for Your Team

 

No scheduled dates for this course right now — but we can deliver it exclusively for your team.

 

Follow the link below and complete the short form to receive a tailored course outline and clear, transparent pricing. Share your focus areas, objectives, timelines, and group size, and we’ll come back to you with a draft programme, estimated investment, and recommended next steps.

Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.

Course Overview

 

Artificial intelligence is transforming how pharmaceutical and biotech organisations discover, develop and commercialise medicines. However, many professionals still struggle to apply AI effectively in real-world settings.

 

This course is designed for R&D, clinical, business and strategy professionals who want to move from understanding AI to using it in practice. It explores how AI can be applied across the pharmaceutical value chain — from drug discovery and clinical development to due diligence and strategic decision-making.

 

Through real-world examples and practical exercises, participants will learn how to identify high-value use cases, apply AI tools, and make faster, more informed decisions.

 

Learn more about how we deliver live online training.

Key Learning Objectives

 

  • Explain AI Fundamentals: Define and differentiate between AI, Machine Learning (ML), and Large Language Models (LLMs).
  • Master New Terminology (walk-the-walk, talk-the-talk): Gain competency in advanced technical concepts including APIs, Model Context Protocols (MCPs), Agentic AI, and Neuro-symbolic AI.
  • Optimize R&D Workflows: Identify specific opportunities to use AI for target identification, molecule generation, and clinical trial optimization.
  • Enhance Due Diligence (DD): Utilize AI tools (e.g., Gemini, NotebookLM, Undermind) to accelerate the digestion of large datasets and improve risk-adjusted deal structuring.
  • Implement AI augmented “Red Teaming”: Use AI-driven “devil’s advocate” techniques to rigorously challenge assumptions and uncover hidden risks in everything from daily workflows to your big project.
  • Navigate Regulatory & Life Cycle Management (LCM): Understand how AI impacts medicine, patient care, patent strategies, line extensions, and market exclusivity.

Who Should Attend?

 

This course is designed for mid-to-senior level professionals across pharma and biotech who need to move from understanding AI to actively applying it in their role.

R&D and Clinical Development

  • CSOs, Heads of Discovery, Clinical Trial Managers, Principal Scientists, Pharmacologists

Business Development & Strategy

  • Heads of BD, Licensing Managers, Biotech Investors, Strategy Leads

Commercial, Medical & Regulatory

  • Medical Science Liaisons, Brand Managers, Regulatory Affairs Professionals, Patent Attorneys

Digital, Data & Transformation

  • IT Directors, Digital Transformation Leads, Project Managers, Process Excellence Leads

 

Ideal Participant

Professionals who recognise the growing impact of AI and want the confidence to apply it in real-world pharmaceutical workflows—rather than remain on the sidelines.

 

Course Outline

Course Information

  • The course begins at the time stated below
  • The course is broken up into modules outlined below
  • There will be breaks between modules
Day 1

Module 1: AI Foundations & The “Spook” Factor

  • AI vs. ML vs. Deep Learning: Understanding the hierarchy of intelligence and how ML identifies patterns to make predictive decisions.
  • Large Language Models (LLMs) Under the Hood: A deep dive into transformer architecture (“the brain”), training on massive datasets, and next-token prediction.
  • Managing Limitations: Addressing hallucinations, data security, and the “Faithfulness” of generated outputs.

 

Module 2: Advanced Architectures & New Lingo

  • Agentic AI: Transitioning from chat-based interactions to autonomous systems that independently plan and act to achieve goals.
  • Neuro-symbolic AI & Knowledge Graphs: Combining neural pattern recognition with logical, rule-based reasoning and structured semantic networks (GraphRAG).
  • API & MCP Mastery: Understanding Application Programming Interfaces (APIs) and Model Context Protocols for building custom pharmaceutical “Gems”.

 

Module 3: Strategic Implementation & Pitching

  • Framing the Solution: Learning how to design and “pitch” an AI-driven solution to leadership, moving from concept to actionable success.
  • Evaluating AI Systems: Assessing existing health care AI systems to understand their strengths and weaknesses in clinical and business settings.
  • The Intersection of Data & Science: Case studies on biotech leaders like Flagship Pioneering and Generate: Biomedicines.

 

Module 4: AI in Drug Discovery & Clinical Development

  • Target Identification & Validation: Rapidly analyzing genomics and proteomics to pinpoint disease-causing targets.
  • Generative Biology: Using tools like AlphaFold to design novel drug molecules and predict protein structures from scratch.
  • Clinical Trial 2.0: AI-driven patient recruitment, stratification, and real-time trial monitoring to reduce the “Valley of Death”.
Day 2

Module 5: Forensic Due Diligence & Red Teaming

  • Predictive Intelligence in DD: Moving beyond standard checklists to holistic forensic data-auditing.
  • The Red Teaming Workshop: Appointing a “devil’s advocate” team to rigorously challenge asset assumptions and identify technical or regulatory “kill switches”.
  • Competitive Intelligence (CI): Live demo of URL mining, SEC filing (S-1) analysis, and automated CI reporting.

 

Module 6: Digital Medicine & Ethical Governance

  • Real-World Data (RWD): Leveraging data from wearables and sensors to track behavioral patterns and digital biomarkers.
  • Ethical AI: Ensuring algorithmic trust and identifying potential biases.

 

Module 7: Moving to Action

  • Scenario-Based Assignment: Designing and pitching an end-to-end AI implementation strategy for a specific pharmaceutical challenge.
  • The “Watch One, Learn One, Do One” Finale: Final hands-on lab operationalizing the tools and strategies learned throughout the course.

Reviews

There are no reviews yet.

Be the first to review “

AI for Drug Development & Pharma Strategy

Available for Group Training

Your email address will not be published. Required fields are marked *

Select Your Currency